STOCK TITAN

DocGo Inc. (DCGO) CFO discloses 429,405 RSU award and tax withholding

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

DocGo Inc.'s CFO and Treasurer, Norman Rosenberg, reported equity compensation and related tax withholding transactions. On December 12, 2025, he received 429,405 restricted stock units (RSUs) under DocGo’s 2021 Stock Incentive Plan at a stated price of $0, bringing his beneficial ownership to 1,289,345 shares of common stock.

On December 15, 2025, 65,774 shares were withheld at $0.91 per share to cover his tax liability from earlier RSU grants, reducing his beneficial ownership to 1,223,571 shares. The new RSUs vest in four equal annual installments on each of the first four anniversaries of December 12, 2025, and additional previously granted RSUs are scheduled to vest between December 2026 and December 2028.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
ROSENBERG NORMAN

(Last) (First) (Middle)
C/O DOCGO INC
685 THIRD AVENUE, 9TH FLOOR

(Street)
NEW YORK NY 10017

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
DocGo Inc. [ DCGO ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
CFO and Treasurer
3. Date of Earliest Transaction (Month/Day/Year)
12/12/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 12/12/2025 A 429,405(1) A $0 1,289,345(2) D
Common Stock 12/15/2025 F 65,774(3) D $0.91 1,223,571(2) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan"). The RSUs will vest in four equal annual installments on each of the first four anniversaries of December 12, 2025, subject to the terms of the Plan. Each RSU represents the right to receive, upon vesting, one share of Common Stock, subject to the terms of the Plan.
2. In addition to the RSUs granted on December 12, 2025, this amount reflects: (i) 259,546 RSUs granted pursuant to the Plan that will vest in three equal annual installments on each of December 12, 2026, December 12, 2027 and December 12, 2028; and (ii) 191,860 RSUs granted pursuant to the Plan that will vest in two equal annual installments on each of December 12, 2026 and December 12, 2027, in each case subject to the terms of the Plan. Each RSU represents the right to receive, upon vesting, one share of Common Stock, subject to the terms of the Plan.
3. The reported transaction reflects the withholding of RSUs in satisfaction of the Reporting Person's tax liability. The RSUs were granted to the Reporting Person on December 12, 2023 and December 12, 2024 pursuant to the Plan.
Remarks:
/s/ Jerilyn Laskie, as Attorney-in-Fact for Norman Rosenberg 12/16/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did DocGo (DCGO) report for its CFO?

DocGo’s CFO and Treasurer, Norman Rosenberg, reported receiving 429,405 restricted stock units (RSUs) on December 12, 2025 and a separate tax withholding transaction involving 65,774 shares on December 15, 2025.

How many DocGo shares does the CFO beneficially own after these transactions?

Following the reported transactions, Norman Rosenberg beneficially owns 1,223,571 shares of DocGo common stock in direct ownership.

What are the vesting terms of the 429,405 RSUs granted to the DocGo CFO?

The 429,405 RSUs granted on December 12, 2025 will vest in four equal annual installments on each of the first four anniversaries of December 12, 2025, under DocGo’s 2021 Stock Incentive Plan.

What additional RSU awards does the DocGo CFO hold and when do they vest?

In addition to the new grant, the reported holdings include 259,546 RSUs vesting in three equal installments on December 12, 2026, December 12, 2027 and December 12, 2028, and 191,860 RSUs vesting in two equal installments on December 12, 2026 and December 12, 2027, all under the same plan.

Why were 65,774 DocGo shares reported as disposed of at $0.91?

The 65,774 shares at $0.91 per share reflect shares withheld to satisfy Norman Rosenberg’s tax liability arising from RSUs granted to him on December 12, 2023 and December 12, 2024.

Is the DocGo CFO’s filing made individually or with other reporting persons?

The report is a Form filed by one reporting person, covering transactions by Norman Rosenberg only.

DOCGO INC

NASDAQ:DCGO

DCGO Rankings

DCGO Latest News

DCGO Latest SEC Filings

DCGO Stock Data

92.08M
88.43M
7.31%
52.38%
4.13%
Medical Care Facilities
Services-health Services
Link
United States
NEW YORK